Replication of human immunodeficiency virus-1 in primary human T cells is dependent on the autocrine secretion of tumor necrosis factor through the control of nuclear factor-κB activation

Journal of Allergy and Clinical Immunology

Volumn 100, Issue 6 I, 1997, Pages 838-845

  Muñoz Fernández, M Angeles ^a,b   Navarro, Joaquín ^a   Garcia, Angel ^b   Punzón, Carmen ^b   Fernández Cruz, Eduardo ^a   Fresno, Manuel ^b  

^a HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Activation; Acute infection; Cytokines; Human immunodeficiency virus; Nuclear factor B; Primary T lymphocytes; Tumor necrosis factor

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; NEUTRALIZING ANTIBODY; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR;

ARTICLE; AUTOCRINE EFFECT; CYTOKINE PRODUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE DEPLETION; PRIORITY JOURNAL; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

EID: 0031395247     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-6749(97)70282-3     Document Type: Article

References (46)

1. Fauci AS. Multifactorial nature of human immunodeficiency virus disease: implications for therapy. Science 1993;262:1011-8.
2. Levy JA. Pathogenesis of human immunodeficiency virus infection. Microbiol Rev 1993;57:183-289.
3. Rosenberg ZF, Fauci AS. Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression. Jmmunol Today 1990;11:176-80.
4. Clerici M, Shearer GM. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol Today 1994;15:575-81.
5. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, Tenner-Racz K. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 1993;362:359-62.
6. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, Fox CH, et al. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 1993;362:355-8.
7. Antoni BA, Stein SB, Rabson AB. Regulation of human immunodeficiency virus infection: implications for pathogenesis. Adv Virus Res 1994;43:53-145.
8. McDougal JS, Mawle A, Cort SP, Nicholson JKA, Cross GD, Scheppler-Cambell JA, et al. Cellular tropism of the human retrovirus HTLV-III/LAV, I: role of T cell activation and expression of the T4 antigen. J Immunol 1985;135:3151-62.
9. Zack J, Arrigo SJ, Weitsman SR, Go AS, Haislip A, Chen IS. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals labile, latent viral structure. Cell 1990;61:213-22.
10. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991;254:423-7.
11. Cullen BR. Regulation of immunodeficiency virus replication. Annu Rev Microbiol 1991;45:423-7.
12. Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992;6:347-63.
13. Nabel G, Baltimore D. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 1987;326:711-3.
14. Liou H, Baltimore D. Regulation of the NF-κB/rel transcription factor and I-κB inhibitor system. Curr Opin Cell Biol 1993;5:477-87.
15. Baeuerle PA, Henkel T. Function and activation of NF-κB in the immune system. Annu Rev Immunol 1994;12:141-79.
16. Lowenthal JW, Ballard DW, Böhnlein E, Greene WC. Tumor necrosis factor-α activation of the IL-2 receptor-α gene involves the induction of κB-specific DNA binding proteins. J Immunol 1989;142:3121-8.
17. Hazan U, Thomas D, Alcamí J, Bachelerie F, Israel N, Yssel H, et al. Stimulation of a human T-cell clone with anti-CD3 or tumor necrosis factor induces NF-κB translocation but not human immunodeficiency virus 1 enhancer-dependent transcription. Proc Natl Acad Sci U S A 1990;87:7861-5.
18. Molitor JA, Walker WH, Doerre S, Ballard DW, Greene WC. NF-κB: a family of inducible and differentially expressed enhancer-binding proteins in human T cells. Proc Natl Acad Sci USA 1990;87:10028-32.
19. Jamieson C, McCaffrey PG, Rao A, Sen R. Physiologic activation of T cells via the T cell receptor induces NF-κB. J Immunol 1991;147:416-20.
20. Meltzer MS, Skillman DR, Hoover DL, et al. Macrophages and the human immunodeficiency virus. Immunol Today 1990;11:217-23.
21. Poli G, Fauci AS. The role of monocyte/macrophages and cytokines in the pathogenesis of HIV infection. Pathobiology 1992;60:246-51.
22. Poli G, Fauci AS. Cytokine modulation of HIV expression. Semin Immunol 1993;5:165-73.
23. Poli G, Kinter A, Justement JS, Kehrl JH, Bressler P, Stanley S, et al. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc Natl Acad Sci U S A 1990;87:782-5.
24. Folks TM, Clouse KA, Justment JS, Rabsou A, Due E, Kehrl JH, et al. Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci U S A 1989;86:2365-9.
25. Duh EJ, Maury WJ, Folks TM, Fauci AS, Rabson AB. Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc Natl Acad Sci U S A 1989;86:5974-8.
26. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor a and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor KB. Proc Natl Acad Sci U S A 1989;86:2336-40.
27. Vilcek J, Lee TH. Tumor necrosis factor: new insights into the molecular mechanisms of its multiple actions. J Biol Chem 1991;266:7313-6.
28. Sung SS, Bjorndahl JM, Wang CY, Kao HT, Fu SM. Production of tumor necrosis factor/cachectin by human T cell lines and peripheral blood T lymphocytes stimulated by phorbol myristate acetate and anti-CD3 antibody. J Exp Med 1988;167:937-53.
29. Steffen M, Ottmann OG, Moore MA. Simultaneous production of tumor necrosis factor-alpha and lymphotoxin by normal T cells after induction with IL-2 and anti-T3. J Immunol 1988;140:2621-4.
30. Pimentel-Muiños FX, Muñoz-Fernández MA, Fresno M. Control of T lymphocyte activation and interleukin-2 receptor expression by endogenously secreted lymphokines. J Immunol 1994;152:5714-22.
31. Merill JE, Koyanagi Y, Chen IS. Interleukin-1 and tumor necrosis factor a can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J Virol 1989;63:4404-8.
32. Biswas DK, Salas TR, Wang F, Ahlers CH, Dezube BJ, Pardee AB. A Tat-induced auto-up-regulatory loop for superactivation of the human immunodeficiency virus type 1 promoter. J Virol 1995;69:7437-44.
33. Aukrust P, Liabakk NB, Muller F, Lien E, Espevik T, Froland SS. Serum levels of tumor necrosis factor-α (TNF) and soluble TNF receptors in human immunodeficiency virus type 1 infection: correlation to clinical, immunological and virological parameters. J Infect Dis 1994;169:420-4.
34. Alcamí J, Laín de Lera T, Folgueira L, Pedraza MA, Jacque JM, Bachelerie F, et al. Absolute dependence on κB responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes. EMBO J 1995;14:1552-60.
35. Navarro J, Punzón MC, Pizarro A, Fernández-Cruz E, Fresno M, Muñoz-Fernández MA. Pentoxifylline inhibits acute HIV-1-replication in human T cells by a mechanism not involving inhibition of tumor necrosis factor synthesis or nuclear factor kappa-B activation. AIDS 1996;10:469-75.
36. Bachelerie F, Alcami J, Arenzana-Seisdedos F, Hazan U, Virelizier JL. HIV enhancer activity perpetuated by NF-κB induction on infection of monocytes. Nature 1991;350:709-12.
37. Kang SM, Tran AC, Grilli M, Lenardo MJ. NK-kappa B subunit regulation in nontransformed CD4+ T lymphocytes. Science 1992;256:1452-6.
38. Liu J, Perkins ND, Schmid RM, Nabel GJ. Specific NF-κB subunits act in concert with Tat to stimulate human immunodeficiency virus type I transcription. J Virol 1992;66:3883-7.
39. + model of chronic infection. J Immunol 1993;150:625-34.
40. Vyakarnam A, McKeating AJ, Meager A, Beverly PC. Tumor necrosis factors α, β induced by HIV-1 in peripheral blood mononuclear cells potentiate virus replication. AIDS 1990;4:21-7.
41. Kinter AL, Poli G, Fauci AS. HIV replication in IL-2-stimulated peripheal blood mononuclear cells is driven in autocrine/paracrine manner by endogenous cytokines. J Immunol 1995;154:2448-59.
42. Pimentel-Muiños FX, Mazana J, Fresno M. Biphasic control of nuclear factor-κB activation by the T cell receptor complex: role of tumor necrosis factor. Eur J Immuftol 1995;25:179-86.
43. Molina JM, Scadden DT, Byrn R, Dinarello CA, Groopman JF. Production of tumor necrosis factor α and interleukin-1β by monocytic cells infected with human immunodeficiency virus. J Clin Invest 1990;84:733-7.
44. Rieckmann P, Poli G, Fox CH, Kehrl JH, Fauci AS. Recombinant gp120 specifically enhances tumor necrosis factor-alpha production and Ig secretion in B lymphocytes from HIV-infected individuals but not from seronegative donors. J Immunol 1991;147:2922-7.
45. Reisinger EC, Kern P, Ernst M, Bock P, Flad HD, Dietrich M. Inhibition of HIV progression by dithiocarb. German DTC Study Group. Lancet 1990;335:679-82.
46. Debuze BJ. Pentoxifyllirie for the treatment of infection with human immunodeficiency virus. Clin Infect Dis 1994;18:285-7.